麻疹病毒发病率和麻疹病毒第一剂疫苗接种对近期艾滋病毒检测的影响

IF 3.4 2区医学 Q3 IMMUNOLOGY

AIDS Pub Date : 2024-07-11 DOI:10.1097/qad.0000000000003919

Rebecca Y Linfield, David J.G. Slusky, Leon S. Moskatel

{"title":"麻疹病毒发病率和麻疹病毒第一剂疫苗接种对近期艾滋病毒检测的影响","authors":"Rebecca Y Linfield, David J.G. Slusky, Leon S. Moskatel","doi":"10.1097/qad.0000000000003919","DOIUrl":null,"url":null,"abstract":"\n \n Understanding the impact of Mpox incidence and Mpox first dose vaccination on recent HIV testing is critical to better address both epidemics. We conducted a regression analysis of Mpox incidence and Mpox first dose vaccinations with recent HIV testing during the 2022 Mpox epidemic. We found that increased Mpox first dose vaccination was associated with a decrease in recent HIV testing in men but not women. Mpox incidence was not associated with changes in HIV testing.\n","PeriodicalId":7502,"journal":{"name":"AIDS","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The impact of Mpox virus incidence and Mpox virus first-dose vaccination on recent HIV testing\",\"authors\":\"Rebecca Y Linfield, David J.G. Slusky, Leon S. Moskatel\",\"doi\":\"10.1097/qad.0000000000003919\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n \\n Understanding the impact of Mpox incidence and Mpox first dose vaccination on recent HIV testing is critical to better address both epidemics. We conducted a regression analysis of Mpox incidence and Mpox first dose vaccinations with recent HIV testing during the 2022 Mpox epidemic. We found that increased Mpox first dose vaccination was associated with a decrease in recent HIV testing in men but not women. Mpox incidence was not associated with changes in HIV testing.\\n\",\"PeriodicalId\":7502,\"journal\":{\"name\":\"AIDS\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/qad.0000000000003919\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/qad.0000000000003919","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

了解麻风腮发病率和麻风腮第一剂疫苗接种对近期艾滋病检测的影响对于更好地应对这两种流行病至关重要。我们对 2022 年麻风腮疫情期间麻风腮发病率和麻风腮第一剂疫苗接种率与近期 HIV 检测进行了回归分析。我们发现，痘苗首剂接种率的增加与男性近期 HIV 检测率的下降有关，但与女性无关。麻疹发病率与 HIV 检测的变化无关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The impact of Mpox virus incidence and Mpox virus first-dose vaccination on recent HIV testing

Understanding the impact of Mpox incidence and Mpox first dose vaccination on recent HIV testing is critical to better address both epidemics. We conducted a regression analysis of Mpox incidence and Mpox first dose vaccinations with recent HIV testing during the 2022 Mpox epidemic. We found that increased Mpox first dose vaccination was associated with a decrease in recent HIV testing in men but not women. Mpox incidence was not associated with changes in HIV testing.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

AIDS 医学-病毒学

CiteScore

5.90

自引率

5.30%

发文量

478

审稿时长

3 months

期刊介绍： Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals. With 18 issues per year, AIDS guarantees the authoritative presentation of significant advances. The Editors, themselves noted international experts who know the demands of your work, are committed to making AIDS the most distinguished and innovative journal in the field. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.